Brain, Mood & Sleep
DSIP / BPC-157 / CJC-1295
A nighttime protocol pairing sleep architecture support with tissue repair and growth hormone signaling.
- Physician reviewed
- 503A pharmacy compounded
- Patient-specific prescription
Formats & pricing
- combination vial — reconstituted injectable$240
Pricing reflects the compounded preparation and physician review. Final therapy and dosing are determined only after your intake is reviewed.
Overview
What is DSIP / BPC-157 / CJC-1295?
This preparation targets the overnight recovery window — DSIP for sleep depth, BPC-157 for tissue repair, and CJC-1295 for growth hormone release, all of which are most active during sleep.
Mechanism
How it works
Growth hormone release peaks during slow-wave sleep, and tissue repair follows the same rhythm. The rationale for this stack is timing: each component works within the same nightly window.
Wellness support
Potential wellness support areas
These areas are commonly discussed within wellness-focused protocols. They are educational statements, not medical claims or guarantees of outcome.
- Explored for sleep depth and overnight recovery
- Discussed for body composition and repair
- Potential support for daytime energy
- Consolidated into a single nightly injection
Administration
Format & dosing
One subcutaneous injection nightly before bed. Your physician sets dosing and cycle length after intake review.
Labs & monitoring
Labs, testing & monitoring
Your physician determines the final testing requirements for DSIP / BPC-157 / CJC-1295 after reviewing your intake. The panels below are what is commonly reviewed for this therapy — they are educational guidance, not a fixed requirement.
Bloodwork status
Baseline Labs Generally Required
Commonly reviewed at baseline
- IGF-1
- Comprehensive metabolic panel (CMP)
- Fasting glucose and A1c
- Lipid panel
- Thyroid panel (TSH, free T4)
Follow-up & monitoring
Because a growth hormone secretagogue is included, IGF-1 and glycemic markers are commonly rechecked at 8 to 12 weeks.
Who may not be a candidate
- Pregnancy or nursing
- Active malignancy without oncology clearance
- Known hypersensitivity to the preparation
- Untreated obstructive sleep apnea
- Uncontrolled diabetes
Medication interactions
Your physician reviews all prescriptions, supplements, and over-the-counter medications during intake before anything is prescribed.
Safety
Safety & considerations
Compounded, not FDA-approved. Not appropriate with active malignancy. Disclose sleep and psychiatric medications during intake.
Regulatory status: Compounded. Evidence level: Limited. Eligibility, dosing, laboratory requirements, and follow-up care are determined exclusively by a licensed physician after review of your history.
Related therapies
Brain, Mood & Sleep
Semax / Selank
Nootropic injectable stack for focus, mood, and stress resilience.
Provider Determines Testing
Brain, Mood & Sleep
DSIP
Delta sleep-inducing peptide for sleep quality and stress adaptation.
Provider Determines Testing
Brain, Mood & Sleep
Pinealon / PE22-28 / Selank
Neuroprotective and anxiolytic triple combo for brain health and mood.
Provider Determines Testing
Physician reviewed
Every protocol is approved by a licensed physician.
503A compounded
Prepared by licensed US compounding pharmacies.
Patient-specific Rx
Prescriptions are issued in your name only.
No membership
No concierge fee and no subscription to browse or begin.